Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Invivyd, Inc.
  6. News
  7. Summary
    IVVD   US00534A1025

INVIVYD, INC.

(IVVD)
  Report
Delayed Nasdaq  -  01:00 2022-11-25 pm EST
2.140 USD   -5.31%
11/17Invivyd Says it Teamed Up With Population Health Partners to Accelerate Clinical Development Projects
MT
11/17Invivyd, Inc. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
11/17Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical Development in Infectious Diseases Including COVID-19
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about INVIVYD, INC.
11/17Invivyd Says it Teamed Up With Population Health Partners to Accelerate Clinical Develo..
MT
11/17Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical De..
GL
11/17Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical De..
AQ
11/17Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical De..
CI
11/10Transcript : Invivyd, Inc., Q3 2022 Earnings Call, Nov 10, 2022
CI
11/10Invivyd, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
CI
11/10Invivyd Reports Third Quarter 2022 Financial Results and Business Highlights
GL
11/09Invivyd to Participate in Fireside Chat at the Jefferies London Healthcare Conference
GL
11/09Invivyd to Participate in Fireside Chat at the Jefferies London Healthcare Conference
AQ
11/02Invivyd to Host Conference Call on November 10 to Discuss Third Quarter 2022 Financial ..
AQ
10/24Invivyd Announces the Appointment of Christine Lindenboom to Board of Directors
GL
10/24Invivyd Announces the Appointment of Christine Lindenboom to Board of Directors
AQ
10/24Invivyd Announces Board Changes
CI
10/13Invivyd Eliminates Certain Job Positions in 'Resource Realignment' -- Shares up After H..
MT
10/13Invivyd, Inc. Announces Executive Changes
CI
More most relevant news
All news about INVIVYD, INC.
11/17Invivyd Says it Teamed Up With Population Health Partners to Accelerate Clinical Develo..
MT
11/17Invivyd, Inc. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Se..
AQ
11/17Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical De..
GL
11/17Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical De..
AQ
11/17Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical De..
CI
11/10INVIVYD, INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
11/10Transcript : Invivyd, Inc., Q3 2022 Earnings Call, Nov 10, 2022
CI
11/10Invivyd, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
CI
11/10Invivyd Reports Third Quarter 2022 Financial Results and Business Highlights
GL
11/09Invivyd to Participate in Fireside Chat at the Jefferies London Healthcare Conference
GL
More news
News in other languages on INVIVYD, INC.
11/17Invivyd déclare avoir fait équipe avec Population Health Partners pour accélérer les pr..
11/17Invivyd annonce un partenariat avec Population Health Partners pour accélérer le dévelo..
11/10Invivyd, Inc. annonce ses résultats financiers pour le troisième trimestre et les neuf ..
10/24Invivyd annonce des changements au conseil d'administration
10/13Invivyd élimine certains postes dans le cadre d'un " réalignement des ressources " - Le..
10/13Invivyd, Inc. annonce des changements de direction
09/29Invivyd dépose un plateau mixte de 400 millions de dollars
09/13Invivyd, Inc. a changé son ticker d'ADGI à IVVD
09/12Invivyd annonce de multiples candidats anticorps COVID-19 de nouvelle génération et sél..
08/19Achats d'initiés : Adagio Therapeutics
More news
Analyst Recommendations on INVIVYD, INC.
05/16Stifel Adjusts Adagio Therapeutics' Price Target to $5 From $9, Reiterates Hold Rating
MT
01/06Morgan Stanley Downgrades Adagio Therapeutics to Underweight Rating From Equalweight, A..
MT
2021Jefferies Downgrades Adagio Therapeutics to Hold From Buy; Price Target is $10
MT
2021Morgan Stanley Downgrades Adagio Therapeutics to Equalweight from Overweight, Adjusts P..
MT
2021Guggenheim Downgrades Adagio Therapeutics to Neutral From Buy
MT
More recommendations
Press releases
11/17Invivyd, Inc. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Se..
AQ
11/17Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical De..
GL
11/17Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical De..
AQ
11/10INVIVYD, INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
11/10Invivyd Reports Third Quarter 2022 Financial Results and Business Highlights
GL
More press releases
Upcoming event on INVIVYD, INC.